Kowal Investment Group’s Cardinal Health CAH Stock Holding History

Kowal Investment Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	–	–	249
2021 Q3	$0	Buy	+1	New	+$54	﹤0.01%	924

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kowal Investment Group's CAH Position: Q4 2021 in Review

Kowal Investment Group sold out of Cardinal Health (CAH) in Q4 2021, closing a stake of 1 share.

Kowal Investment Group first reported a position in CAH in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 779 funds tracked by Wall St. Rank hold CAH as of Q4 2021.

Kowal Investment Group reported no remaining Cardinal Health position as of Q4 2021 after selling out during the quarter.
Kowal Investment Group sold 1 Cardinal Health share in Q4 2021.
Kowal Investment Group first reported a position in Cardinal Health in Q3 2021 and held it in 1 quarter.
Kowal Investment Group's Cardinal Health position peaked at $0 in Q3 2021.
779 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2021.

Based on Kowal Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.